Literature DB >> 32763116

Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.

Young Jun Shim1, Raneem Khedraki1, Jayeeta Dhar1, Ran Fan1, Nina Dvorina1, Anna Valujskikh1, Robert L Fairchild1, William M Baldwin2.   

Abstract

Allogeneic transplants elicit dynamic T cell responses that are modulated by positive and negative co-stimulatory receptors. Understanding mechanisms that intrinsically modulate the immune responses to transplants is vital to develop rational treatment for rejection. Here, we have investigated the impact of programed cell death-1 (PD-1) protein, a negative co-stimulatory receptor, on the rejection of MHC incompatible kidney transplants in mice. T cells were found to rapidly infiltrate the kidneys of A/J mice transplanted to C57BL/6 mice, which peaked at six days and decline by day 14. The T cells primarily encircled tubules with limited infiltration of the tubular epithelium. Lipocalin 2 (LCN2), a marker of tubular injury, also peaked in the urine at day six and then declined. Notably, flow cytometry demonstrated that most of the T cells expressed PD-1 (over 90% of CD8 and about 75% of CD4 cells) at day six. Administration of blocking antibody to PD-L1, the ligand for PD-1, before day six increased T cell infiltrates and urinary LCN2, causing terminal acute rejection. In contrast, blocking PD-1/PD-L1 interactions after day six caused only a transient increase in urinary LCN2. Depleting CD4 and CD8 T cells virtually eliminated LCN2 in the urine in support of T cells injuring tubules. Thus, our data indicate that PD-1/PD-L1 interactions are not just related to chronic antigenic stimulation of T cells but are critical for the regulation of acute T cell responses to renal transplants.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; acute rejection; inflammation; lymphocytes; renal pathology; transplantation

Mesh:

Substances:

Year:  2020        PMID: 32763116      PMCID: PMC7541419          DOI: 10.1016/j.kint.2020.03.037

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Programmed death-1 targeting can promote allograft survival.

Authors:  Engin Ozkaynak; Liqing Wang; Andrew Goodearl; Kevin McDonald; Shixin Qin; Theresa O'Keefe; Thao Duong; Tammy Smith; Jose-Carlos Gutierrez-Ramos; James B Rottman; Anthony J Coyle; Wayne W Hancock
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

2.  Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection.

Authors:  T Alhamad; K Venkatachalam; G P Linette; D C Brennan
Journal:  Am J Transplant       Date:  2016-03-01       Impact factor: 8.086

3.  Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.

Authors:  Jun Yang; Joyce Popoola; Shakila Khandwala; Nidyanandh Vadivel; Vijay Vanguri; Xueli Yuan; Shirine Dada; Indira Guleria; Chaorui Tian; M Javeed Ansari; Tahiro Shin; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Anil Chandraker
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

4.  Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.

Authors:  Naoki Kohei; Toshiaki Tanaka; Kazunari Tanabe; Naoya Masumori; Nina Dvorina; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2016-04-28       Impact factor: 10.612

5.  Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.

Authors:  Astrid Starke; Maja T Lindenmeyer; Stephan Segerer; Matthias A Neusser; Barbara Rüsi; Daniel M Schmid; Clemens D Cohen; Rudolf P Wüthrich; Thomas Fehr; Ying Waeckerle-Men
Journal:  Kidney Int       Date:  2010-04-14       Impact factor: 10.612

6.  Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Authors:  Toshiro Ito; Takuya Ueno; Michael R Clarkson; Xueli Yuan; Mollie M Jurewicz; Hideo Yagita; Miyuki Azuma; Arlene H Sharpe; Hugh Auchincloss; Mohamed H Sayegh; Nader Najafian
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 7.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

8.  Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.

Authors:  Victoria Gorbacheva; Ran Fan; Robert L Fairchild; William M Baldwin; Anna Valujskikh
Journal:  J Am Soc Nephrol       Date:  2016-03-28       Impact factor: 10.121

Review 9.  Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature.

Authors:  Julia K Winkler; Ralf Gutzmer; Carolin Bender; Nina Lang; Martin Zeier; Alexander H Enk; Jessica C Hassel
Journal:  J Immunother       Date:  2017 Nov/Dec       Impact factor: 4.456

10.  PD1-Expressing T Cell Subsets Modify the Rejection Risk in Renal Transplant Patients.

Authors:  Rebecca Pike; Niclas Thomas; Sarita Workman; Lyn Ambrose; David Guzman; Shivajanani Sivakumaran; Margaret Johnson; Douglas Thorburn; Mark Harber; Benny Chain; Hans J Stauss
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

View more
  4 in total

Review 1.  Acute Kidney Injury Induced by Immune Checkpoint Inhibitors.

Authors:  Ruixue Tian; Jin Liang; Rongshan Li; Xiaoshuang Zhou
Journal:  Kidney Dis (Basel)       Date:  2022-04-04

2.  Resident memory T cells form during persistent antigen exposure leading to allograft rejection.

Authors:  Khodor I Abou-Daya; Roger Tieu; Daqiang Zhao; Rayan Rammal; Faruk Sacirbegovic; Amanda L Williams; Warren D Shlomchik; Martin H Oberbarnscheidt; Fadi G Lakkis
Journal:  Sci Immunol       Date:  2021-03-19

3.  Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine Models.

Authors:  Jordi Guiteras; Laura De Ramon; Elena Crespo; Nuria Bolaños; Silvia Barcelo-Batllori; Laura Martinez-Valenzuela; Pere Fontova; Marta Jarque; Alba Torija; Oriol Bestard; David Resina; Josep M Grinyó; Joan Torras
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 4.  Immune-checkpoint inhibitors: long-term implications of toxicity.

Authors:  Douglas B Johnson; Caroline A Nebhan; Javid J Moslehi; Justin M Balko
Journal:  Nat Rev Clin Oncol       Date:  2022-01-26       Impact factor: 65.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.